Trypanosoma cruzi Antibody, IgM
0051075
Ordering Recommendation
Aid in the diagnosis of Chagas disease (T. cruzi). Order in conjunction with Parasites Smear (Giemsa Stain), Blood (0049025).
Mnemonic
CHAGAS M
Methodology
Semi-Quantitative Indirect Fluorescent Antibody
Performed
Wed
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
- Patient Preparation
- Collect
- Serum separator tube.
- Specimen Preparation
- Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.05 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days of the acute specimens. Mark specimens plainly as acute or convalescent.
- Storage/Transport Temperature
- Refrigerated. Also acceptable: Room temperature or frozen.
- Unacceptable Conditions
- Plasma. Bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid specimens.
- Remarks
- Stability
- After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year
Reference Interval
Less than 1:16: Negative - No significant level of Trypanosoma cruzi IgM antibody detected.
1:16 or greater: Positive - IgM antibodies to Trypanosoma cruzi detected, which may suggest current or recent infection.
1:16 or greater: Positive - IgM antibodies to Trypanosoma cruzi detected, which may suggest current or recent infection.
Interpretive Data
ARUP intends the use of this assay for clinical diagnosis. This assay should not be used for blood donor screening or associated re-entry protocols, or for screening Human Cell and Cellular Tissue-Based Products (HCT/Ps).
Compliance Statement A: Analyte specific reagents (ASR) are used in many laboratory tests necessary for standard medical care and generally do not require U.S. Food and Drug Administration (FDA) approval or clearance. This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. This test should not be regarded as investigational or for research use.
Note
CPT Code(s)
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0051075 | Trypanosoma cruzi Antibody, IgM | 13290-2 |
Aliases
- Chagas Antibody, IgM
- T cruzi IgM Ab